ARTICLE | Company News
OncoMethylome, Merck KGaA deal
June 16, 2008 7:00 AM UTC
OncoMethylome will provide testing services to detect methylation of the methylguanine- DNA methyltransferase ( MGMT) gene promoter in clinical trials of Merck’s cilengitide. Merck will receive a non-...